Dr Daniel Keizman discusses the strategies for optimal bone health management in patients with prostate cancer

Dr Keizman is an expert in Genitourinary Oncology, particularly in prostate, bladder, kidney and testicular cancer; and at present serves as the head of the Genitourinary Oncology service at Meir Medical Center, Israel. He graduated from The Sackler Faculty of Medicine, Tel Aviv University, and then completed his residency in Internal Medicine (at the Tel-Aviv Medical Center), Medical Oncology (at the Tel-Aviv Medical Center) and a Post Doctoral Clinical Fellowship in Genitourinary Oncology at the John Hopkins Hospital, Kimmel Cancer Center, Baltimore, USA. He is the author of numerous studies and review articles published in medical journals, and a reviewer of numerous medical journals. He presented numerous studies in international meetings. His current research activity focuses on genitourinary oncology.

Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU CONNECT

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

publication Scientific Publication
Oncology 
ADCs in HER2+ metastatic breast cancer and management of adverse events

Consensus-based guidance for clinicians and patients

Experts
Prof. Javier Cortés, Prof. Giuseppe Curigliano, Prof. Shaheenah Dawood, Dr Grażyna Suchodolska, Dr Sara Tolaney, Carla Whitbread
Endorsed by
EONS - European Oncology Nursing Society Europa Donna
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca
expert-video-animation Animated Video
Oncology Obstetrics and Gynecology 
Understanding HER2 testing in gynecological cancers

Best practices and treatment implications

Experts
Prof. Fernando A. Soares
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Feb 2026
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Daiichi Sankyo.
symposium Masterclass / SymposiumVideo overview
Oncology 
ER+/HER2- metastatic breast cancer: Highlights from the APBCS 2026 Satellite Symposium

Experts discuss 2L+ treatment strategies in endocrine therapy-eligible patients

Experts
Dr Mastura Md Yusof, Dr Hope S. Rugo, Prof. Matteo Lambertini
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Jan 2026

This programme has been sponsored by Menarini Stemline and is intended for HCPs only 
podcast Video podcast
Oncology 
Metastatic breast cancer: Understanding HER2-low and HER2-ultralow classification

A novel therapeutic framework 

Experts
Dr Komal Jhaveri, Oncology Brothers (Moderators)
  • download Downloadable
    Resources
  • clock 25 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from AstraZeneca 
patient-support Patient Support

Episode

2

of 2

episode
Oncology Endocrinology Rare diseases 
Thriving beyond an EP-NEC diagnosis

Perspectives on treatment and care 

Experts
Jessica Thomas
Endorsed by
NET-Research-Foundation Minkhas mission
  • clock 4 MIN
  • calendar Dec 2025
  • Non-accredited Independent Medical Education

Educational programme supported by an Independent Educational Grant from Boehringer Ingelheim